The page is the record's research on the issuer — no analyst, no rating, no view.

# OSE IMMUNOTHERAPEUTICS (Euronext Paris: FR0012127173) — research page

As of 2026-11-11 · fr-cm-kg · record version 1

## Identity and listing

The issuer is OSE IMMUNOTHERAPEUTICS, listed on Euronext Paris under ticker FR0012127173, ISIN FR0012127173, LEI 969500HIUWVGY6NZSM05. Its security type is Corporate, its segment is not on the record, its sector is NAF 72.11Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). The listing status is listed, not halted.

## The disclosure read

The record holds 24 filings in the twelve months to 2026-11-11, across 18 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-02, 9 days before the record date, and is of type regulatory_filing. The exchange median is 8.5 days cadence, 15.0 filings and 7 days latency across 316 issuers. The sector median is 8.0 days cadence, 20.0 filings and 7.0 days latency across 24 issuers.

## Auditor

The auditor of record is not on the record. The record carries the annual report link only, and the auditor's location and any auditor changes are not on the record.

## Events and halts

The listing, delisting, name change, domicile change and segment move lifecycle lines are not on the record, as the index does not carry a lifecycle type map for this register. The halt flag reads listed, not halted.

## Orderability

The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's own investor-relations page names 4 research houses: Edison, Invest Securities, Kepler Cheuvreux and Edison Securities.

## Open research

The record holds 5 openly published research notes, all by Edison Investment Research: dated 2025-08-29, 2025-06-05, 2024-11-21, 2023-12-12 and 2023-05-24.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.

## Sources

13 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)
- https://recherche-entreprises.api.gouv.fr/search?q=479457715 (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.fr-cm-kg.ai/events/XPAR/FR0012127173 (the disclosure lines)
- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)
- https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.ose-immuno.com/en/investors-2/ (coverage)
- https://www.ose-immuno.com/wp-content/uploads/2025/08/Edison_290825.pdf (open research)
- https://www.ose-immuno.com/wp-content/uploads/2025/06/Edison_050625.pdf (open research)
- https://www.ose-immuno.com/wp-content/uploads/2024/11/Edison-21-November-2024.pdf (open research)
- https://www.ose-immuno.com/wp-content/uploads/2023/12/Edison-note-121223.pdf (open research)
- https://www.ose-immuno.com/wp-content/uploads/2023/09/Edison-240523.pdf (open research)
- https://mcp.fr-cm-kg.ai/record/XPAR/FR0012127173 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/fr/XPAR/FR0012127173 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
